Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine

NCT02016261 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Depressive Disorder

Interventions

DRUG: Fluvoxamine

Sponsor

Moscow Research Institute of Psychiatry

Collaborators

[object Object]